This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Timing matters: choose or avoid depending on goals, fees, and flexibility. This guide offers practical criteria to decide for retirement planning.
21,768 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
asml stock popped today as investors chased AI-driven demand for semiconductor equipment. This guide breaks down what...
A quiet, strategic move by a bank’s wealth management arm adds more exposure to its parent company’s stock. Learn wha...
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
As NetApp gears up for 2026 earnings, investors should focus on cloud services growth, margins, and free cash flow. T...
Palantir stock plunging today is drawing attention from traders and long-term investors alike. This article breaks do...
Investors rally around earnings season, but the big question remains: should abbott labs stock be part of your plan b...
Tesla's Q2 delivery figures offer a clear window into demand trends and pricing power. This guide breaks down what to...
Bank of America stock just surged to a record high as investors await quarterly results. This guide breaks down what ...
As Intuitive Surgical prepares to report earnings, investors weigh the risk/reward of buying the stock now. This guid...
Bloom Energy has surged 497% over the past year, shaking up portfolios and headlines. This guide breaks down what the...
Bitcoin briefly dipped below $65,000 on Sunday as tariff headlines surged, but the crypto recovered Monday amid a bro...